Insiders Catalent, Inc.

Equities

CTLT

US1488061029

Market Closed - Nyse Other stock markets 04:00:01 2024-04-26 pm EDT			5-day change	1st Jan Change
55.92 ^USD	+0.22%		+0.79%	+24.46%

Apr. 12	Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48	MT
Apr. 08	Sector Update: Health Care Stocks Decline Late Afternoon	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Catalent, Inc. Announces Executive Changes	Jan. 16	CI
Activist investor Elliott targets drugmaker BioMarin -sources	Nov. 07	RE
Catalent, Inc. Appoints David McErlane as Group President of Catalent?s Biologics segment, Effective September 25, 2023	23-09-18	CI
Catalent, Inc. Appoints Steven Barg as A Member of the Board of Directors	23-09-11	CI
Catalent Director Greisch Buys 21,000 Shares for $1.1 Million	23-09-01	MT
Catalent Discloses Cooperation Deal With Elliot Investment, Offers Upbeat Fiscal 2024 Revenue Guidance	23-08-29	MT
Catalent, Inc. Announces Board Changes	23-08-29	CI
Catalent, Inc. Announces Board Changes	23-08-29	CI
Catalent to settle with Elliott, explore options -sources	23-08-28	RE
Catalent, Inc. Announces Executive Changes	23-08-01	CI
MOVES-Morgan Stanley hires healthcare services banker Cohen from Truist	23-07-12	RE
Catalent Appoints Matti Masanovich as Chief Financial Officer	23-06-20	MT
Catalent names Matti Masanovich as finance head	23-06-20	RE
Catalent, Inc. Appoints Matti Masanovich as Senior Vice President, Effective July 5, 2023	23-06-20	CI
Catalent Expects Productivity Issues, Costs to Hurt Q3 Results; Interim CFO Named; Shares Tumble 27%	23-04-14	MT
Catalent Expects Productivity Issues, Higher Costs to Impact Fiscal Q3 Results; Names Ricky Hopson Interim CFO	23-04-14	MT
Catalent, Inc. Announces Departure of Thomas Castellano as Senior Vice President	23-04-14	CI
Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary	23-02-13	CI
Catalent, Inc. Announces the Appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America	23-01-17	CI
MiMedx Group Names Ricci Whitlow COO	23-01-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Catalent, Inc.

Equities

CTLT

US1488061029

Insiders

Filters